Mode
Text Size
Log in / Sign up

Ketorolac shows early analgesic advantage for post-endodontic pain at 6 hours in meta-analysis

Ketorolac shows early analgesic advantage for post-endodontic pain at 6 hours in meta-analysis
Photo by Navy Medicine / Unsplash
Key Takeaway
Consider ketorolac for early post-endodontic pain control, recognizing its advantage may be limited to the first 6 hours.

This systematic review and meta-analysis evaluated the comparative effectiveness of ketorolac versus other analgesic agents for managing post-endodontic pain following root canal therapy. The analysis included 7 studies for qualitative assessment and 5 studies for quantitative synthesis, though specific patient characteristics and study settings were not reported. The primary outcome was analgesic effect measured at 6, 12, and 24 hours post-administration, with a secondary outcome assessing the proportion of patients requiring supplementary drug treatment.

Results showed a statistically significant difference favoring ketorolac for analgesic effect at 6 hours post-administration. However, no statistically significant differences were found between ketorolac and comparators at 12 or 24 hours. The analysis also indicated a lower proportion of patients required supplementary drug treatment when receiving ketorolac, though specific effect sizes, absolute numbers, and confidence intervals were not reported for any outcomes.

Safety and tolerability data were not reported in the available evidence. Key limitations include the small number of studies available for quantitative analysis (5 studies), mixed results in the qualitative assessment (5 studies favored ketorolac, 1 reported similar effects, and 1 concluded ketorolac was less effective), and lack of reported patient characteristics, effect magnitudes, and safety profiles. The practice relevance is restrained: while ketorolac may offer early pain control advantage and reduce rescue medication needs, clinicians should recognize this benefit appears limited to the first 6 hours post-administration.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
OBJECTIVES: Effective management of post-endodontic pain is crucial for patient comfort. Although ketorolac is used for this purpose, its efficacy relative to other analgesics remains uncertain. This study systematically assesses evidence from randomized clinical trials that investigate the comparative effectiveness of ketorolac and other analgesic agents for the control of post-endodontic pain. MATERIAL AND METHODS: This study conducted a comprehensive search across several databases, including PubMed, Web of Science, ScienceDirect, Cochrane Library, Embase, Scopus, SinoMed, CNKI, Webvpn, and Wanfang Data. Search deadline was around August 2025. The study employed the inverse variance approach and a random effects model to analyze continuous data, utilizing the standardized mean as the comprehensive effect indicator. For dichotomous data, this study applied the risk ratio (RR), fixed-effect analysis model, and Mantel-Haenszel statistical methods. RESULTS: Our database search identified 386 potentially relevant studies. Ultimately, seven studies were selected for qualitative analysis, and five were chosen for quantitative analysis. The qualitative assessment indicated that five studies favored ketorolac, one study reported similar analgesic effects between ketorolac and alternative medications, while one study concluded that ketorolac was less effective. The quantitative analysis demonstrated a statistically significant difference in the analgesic effect of ketorolac compared to other drugs at 6 h post-administration. However, the analgesic effects of ketorolac did not show statistically significant differences compared to other medications at 12 or 24 h post-administration. Additionally, a lower proportion of patients required supplementary drug treatment after receiving ketorolac compared to those treated with other analgesics. CONCLUSION: This meta-analysis concluded that ketorolac is effective for managing post-endodontic pain within the first 6 h and reduces the need for rescue medication compared to alternatives, thereby supporting its use as a favorable option following root canal treatment.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.